Recent Progress of Nanomedicine in the Treatment of Central Nervous System Diseases

Abstract Central nervous system (CNS) diseases, mainly including neurodegenerative diseases and psychiatric diseases, have become the leading cause of death and disability in the world today, which bring huge suffering to both patients and their families. Nanomedicine is an emerging and rapidly evolving discipline that mainly involves the application of nanoparticles in the diagnosis and treatment of various diseases. Although many challenges in the clinical application of nanomedicine still exist, the prospects for development cannot be ignored. Furthermore, better outcomes for patients with CNS diseases can be expected with the rapid development of nanotechnology in diagnosis and treatment. In the present review, an overview is given of the outstanding recent progress of nanomedicine from three aspects: drug delivery, imaging, and therapy in CNS diseases.